Bio-Rad officer James Barry proposes $540K share sale

The notice assigns an aggregate market value of $539,876.82 to the proposed sale and lists three restricted-stock acquisition entries.

Available on EDGAR 11/09/2026 - 04:20 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:19 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Bio-Rad Laboratories, Inc. officer James Barry reported a proposed sale of 1,400 common shares, with an aggregate market value of $539,876.82. The approximate sale date is November 9, 2026, through Morgan Stanley Smith Barney LLC; the notice names the NYSE as the exchange. The shares are reported as restricted stock acquired from the issuer in three entries: 156 on September 1, 658 on September 5, and 586 on September 6, 2026. Bio-Rad Laboratories, Inc. had 21,832,130 shares outstanding.

Key Figures

Common shares to be sold: 1,400 shares Aggregate market value: $539,876.82 Shares outstanding: 21,832,130 shares +3 more

6 metrics

Common shares to be sold 1,400 shares Proposed sale

Aggregate market value $539,876.82 Proposed sale

Shares outstanding 21,832,130 shares Issuer share count

Restricted stock acquired 156 shares September 1, 2026; acquired from the issuer

Restricted stock acquired 658 shares September 5, 2026; acquired from the issuer

Restricted stock acquired 586 shares September 6, 2026; acquired from the issuer

Key Terms

Restricted Stock, Aggregate Market Value, Approximate Date of Sale

3 terms

Restricted Stock financial

"Restricted Stock acquired from the issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate Market Value financial

"Aggregate Market Value: $539,876.82"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Approximate Date of Sale financial

"Approximate Date of Sale: 11/09/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BIO shares does James Barry plan to sell?

James Barry reported a proposed sale of 1,400 common shares, with an aggregate market value of $539,876.82. The approximate sale date is November 9, 2026, and Morgan Stanley Smith Barney LLC is named as the broker.

When did James Barry acquire the BIO shares listed for sale?

The notice lists restricted stock acquired from the issuer on September 1, 2026 (156 shares), September 5, 2026 (658 shares), and September 6, 2026 (586 shares).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002022345
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BIO-RAD LABORATORIES, INC.
SEC File Number	001-07928
Address of Issuer	1000 ALFRED NOBEL DRIVE HERCULES CALIFORNIA 94547
Phone	510-724-7000
Name of Person for Whose Account the Securities are To Be Sold	JAMES BARRY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1400	539876.82	21832130	11/09/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock	Issuer			156	09/01/2026	Not Applicable
Common	09/05/2026	Restricted Stock	Issuer			658	09/05/2026	Not Applicable
Common	09/06/2026	Restricted Stock	Issuer			586	09/06/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/James Barry
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)